Potassium Iodide: Clinical Trials

4 trials of Potassium Iodide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 terminated. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Active not recruiting 1, Terminated 1
Phase 31Completed 1

Follow Potassium Iodide: new trials by email Literature Review of Potassium Iodide trials Research Report on Potassium Iodide

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Irinotecan, Temozolomide, Bevacizumab - Recurrent Medulloblastoma, Recurrent Ependymoma
Phase 2Active not recruitingPediatric Brain Tumor Consortium622022-04-042026-07-28
Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars
Silver diamine fluoride/ potassium iodide, Silver diamine fluoride, Resin modified glass ionomer cement - Tertiary Dentine, Indirect Pulp Capping
Phase 2 / Phase 3CompletedNourhan M.Aly1082019-11-012022-05-19
Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy
Bexxar (tositumomab), External beam radiotherapy (XRT), Potassium Iodide (KI) - Lymphoma, Non-Hodgkin
Phase 2TerminatedStanford University82007-01-012017-03-29
Phase 2 Study of Bexxar in Relapsed/Refractory DLCL
Bexxar, Acetaminophen, Diphenhydramine - Lymphoma
Phase 2CompletedSusan Knox92004-09-012017-03-30

Conditions studied

Dentin, Secondary (1)  ·  Ependymoma (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Medulloblastoma (1)

Sponsors

Nourhan M.Aly (1)  ·  Pediatric Brain Tumor Consortium (1)  ·  Stanford University (1)  ·  Susan Knox (1)

Countries

United States (3)  ·  Egypt (1)

Top investigators

Susan J Knox (2)  ·  Fontana Margherita (1)  ·  Magda El-Tekeya, PhD (1)  ·  Marwa Baraka, M.Sc (1)  ·  Matthias Karajannis, MD, MS (1)  ·  Niveen Bakry, PhD (1)

Results publications

PMID 36253166, PMID 36878216

NIH funding

UM1CA081457 (1)